Across TCGA pan-cancer cohorts, TRIM75P Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated TRIM75P data layer compared with 13 for mass-spec protein.
The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher TRIM75P Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated TRIM75P expression acts as an unfavorable survival marker.
SKCM are the cancer types where TRIM75P Mutation most reproducibly stratifies survival.